Background Decisional regret (DR) is an important patient-reported outcome, reflecting patients’ retrospective evaluation of ...
Objective This study aimed to explore how postgraduate physicians experience and articulate their professional development ...
Background Australian-modified Karnofsky Performance Status (AKPS) is recommended as part of the OACC (Outcomes And Complexity Collaborative) suite of measures to assess palliative patients‘ ...
Objective To compare the analgesic efficacy, adverse effect profile, incidence of acute pain crises and opioid-sparing effects of intravenous ketamine versus lignocaine infusions in patients with ...
PaSo paracetamol with strong opioids trial: paracetamol versus placebo in conjunction with strong opioids for cancer pain—a pilot randomised placebo-controlled withdrawal trial ...
2 School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK Correspondence to Dr Christopher J McDermott, Sheffield Institute for Translational Neuroscience (SITraN), ...
Background Nurses play a unique and critical role in palliative care, and it is noteworthy that nurses often encounter ethical dilemmas in this field. Objective This review aims to conduct a ...
Correspondence to Koji Amano, Department of Palliative Medicine, Palliative Care Team, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka 534-0021, Japan; ...
Correspondence to Dr Elizabeth A Davies, Cancer Epidemiology, Population and Global Health, School of Cancer and Pharmaceutical Sciences Faculty of Life Sciences and Medicine, King’s College London, ...
Background Dyspnoea is a prevalent, debilitating symptom in advanced life-limiting illnesses. While opioids and non-pharmacological measures remain foundational, refractory breathlessness presents a ...
Objectives Virtual health has the potential to improve access to supportive oncology and improve operational performance; however, real-world data across multi-speciality cancer programmes are limited ...
Objective Minimal clinically important differences (MCIDs) are used in palliative care trials to guide sample size ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results